TY - JOUR AU - Zhao, Z. AU - Okusaga, O. O. AU - Quevedo, J. AU - Soares, J. C. AU - Teixeira, A. L. PY - 2016 DA - 2016// TI - The potential association between obesity and bipolar disorder: a meta-analysis JO - J Affect Disord VL - 202 UR - https://doi.org/10.1016/j.jad.2016.05.059 DO - 10.1016/j.jad.2016.05.059 ID - Zhao2016 ER - TY - JOUR AU - Flegal, K. M. AU - Kruszon-Moran, D. AU - Carroll, M. D. AU - Fryar, C. D. AU - Ogden, C. L. PY - 2016 DA - 2016// TI - Trends in obesity among adults in the United States, 2005 to 2014 JO - JAMA VL - 315 UR - https://doi.org/10.1001/jama.2016.6458 DO - 10.1001/jama.2016.6458 ID - Flegal2016 ER - TY - JOUR AU - Ogden, C. L. AU - Carroll, M. D. AU - Fryar, C. D. AU - Flegal, K. M. PY - 2015 DA - 2015// TI - Prevalence of obesity among adults and youth: United States, 2011–2014 JO - NCHS Data Brief VL - 219 ID - Ogden2015 ER - TY - JOUR AU - Catapano, L. AU - Castle, D. PY - 2004 DA - 2004// TI - Obesity in schizophrenia: what can be done about it? JO - Australas Psychiatry VL - 12 UR - https://doi.org/10.1046/j.1039-8562.2003.02054.x DO - 10.1046/j.1039-8562.2003.02054.x ID - Catapano2004 ER - TY - JOUR AU - Dickerson, F. B. AU - Brown, C. H. AU - Daumit, G. L. AU - Fang, L. AU - Lijuan, F. AU - Goldberg, R. W. PY - 2006 DA - 2006// TI - Health status of individuals with serious mental illness JO - Schizophr Bull VL - 32 UR - https://doi.org/10.1093/schbul/sbj048 DO - 10.1093/schbul/sbj048 ID - Dickerson2006 ER - TY - JOUR AU - Kolotkin, R. L. AU - Corey-Lisle, P. K. AU - Crosby, R. D. AU - Swanson, J. M. AU - Tuomari, A. V. AU - L’italien, G. J. PY - 2008 DA - 2008// TI - Impact of obesity on health-related quality of life in schizophrenia and bipolar disorder JO - Obesity VL - 16 UR - https://doi.org/10.1038/oby.2007.133 DO - 10.1038/oby.2007.133 ID - Kolotkin2008 ER - TY - JOUR AU - Fagiolini, A. AU - Frank, E. AU - Houck, P. R. AU - Mallinger, A. G. AU - Swartz, H. A. AU - Buysse, D. J. PY - 2002 DA - 2002// TI - Prevalence of obesity and weight change during treatment in patients with bipolar I disorder JO - J Clin Psychiatry VL - 63 UR - https://doi.org/10.4088/JCP.v63n0611 DO - 10.4088/JCP.v63n0611 ID - Fagiolini2002 ER - TY - JOUR AU - Fagiolini, A. AU - Frank, E. AU - Scott, J. A. AU - Turkin, S. AU - Kupfer, D. J. PY - 2005 DA - 2005// TI - Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians JO - Bipolar Disord VL - 7 UR - https://doi.org/10.1111/j.1399-5618.2005.00234.x DO - 10.1111/j.1399-5618.2005.00234.x ID - Fagiolini2005 ER - TY - JOUR AU - Garcia-Portilla, M. P. AU - Saiz, P. A. AU - Benabarre, A. AU - Sierra, P. AU - Perez, J. AU - Rodriguez, A. PY - 2008 DA - 2008// TI - The prevalence of metabolic syndrome in patients with bipolar disorder JO - J Affect Disord VL - 106 UR - https://doi.org/10.1016/j.jad.2007.06.002 DO - 10.1016/j.jad.2007.06.002 ID - Garcia-Portilla2008 ER - TY - JOUR AU - McElroy, S. L. AU - Frye, M. A. AU - Suppes, T. AU - Dhavale, D. AU - Keck, P. E. AU - Leverich, G. S. PY - 2002 DA - 2002// TI - Correlates of overweight and obesity in 644 patients with bipolar disorder JO - J Clin Psychiatry VL - 63 UR - https://doi.org/10.4088/JCP.v63n0306 DO - 10.4088/JCP.v63n0306 ID - McElroy2002 ER - TY - JOUR AU - Lindenmayer, J. P. AU - Khan, A. AU - Kaushik, S. AU - Thanju, A. AU - Praveen, R. AU - Hoffman, L. PY - 2012 DA - 2012// TI - Relationship between metabolic syndrome and cognition in patients with schizophrenia JO - Schizophr Res VL - 142 UR - https://doi.org/10.1016/j.schres.2012.09.019 DO - 10.1016/j.schres.2012.09.019 ID - Lindenmayer2012 ER - TY - JOUR PY - 2004 DA - 2004// TI - Consensus development conference on antipsychotic drugs and obesity and diabetes JO - J Clin Psychiatry VL - 65 UR - https://doi.org/10.4088/JCP.v65n0219 DO - 10.4088/JCP.v65n0219 ID - ref12 ER - TY - JOUR AU - Meyer, J. M. AU - Mao, Y. AU - Pikalov, A. AU - Cucchiaro, J. AU - Loebel, A. PY - 2015 DA - 2015// TI - Weight change during long-term treatment with lurasidone: pooled analysis of studies in patients with schizophrenia JO - Int Clin Psychopharmacol VL - 30 UR - https://doi.org/10.1097/YIC.0000000000000091 DO - 10.1097/YIC.0000000000000091 ID - Meyer2015 ER - TY - JOUR AU - Newcomer, J. W. PY - 2005 DA - 2005// TI - Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review JO - CNS Drugs VL - 19 ID - Newcomer2005 ER - TY - JOUR AU - Newcomer, J. W. PY - 2007 DA - 2007// TI - Metabolic considerations in the use of antipsychotic medications: a review of recent evidence JO - J Clin Psychiatry VL - 68 ID - Newcomer2007 ER - TY - JOUR AU - Potvin, S. AU - Zhornitsky, S. AU - Stip, E. PY - 2015 DA - 2015// TI - Antipsychotic-induced changes in blood levels of leptin in schizophrenia: a meta-analysis JO - Can J Psychiatry VL - 60 ID - Potvin2015 ER - TY - JOUR AU - Bartoli, F. AU - Crocamo, C. AU - Clerici, M. AU - Carrà, G. PY - 2015 DA - 2015// TI - Second-generation antipsychotics and adiponectin levels in schizophrenia: a comparative meta-analysis JO - Eur Neuropsychopharmacol VL - 25 UR - https://doi.org/10.1016/j.euroneuro.2015.06.011 DO - 10.1016/j.euroneuro.2015.06.011 ID - Bartoli2015 ER - TY - JOUR AU - Muench, J. AU - Hamer, A. M. PY - 2010 DA - 2010// TI - Adverse effects of antipsychotic medications JO - Am Fam Physician VL - 81 ID - Muench2010 ER - TY - JOUR AU - Leucht, S. AU - Cipriani, A. AU - Spineli, L. AU - Mavridis, D. AU - Orey, D. AU - Richter, F. PY - 2013 DA - 2013// TI - Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis JO - Lancet VL - 382 UR - https://doi.org/10.1016/S0140-6736(13)60733-3 DO - 10.1016/S0140-6736(13)60733-3 ID - Leucht2013 ER - TY - JOUR AU - Citrome, L. PY - 2011 DA - 2011// TI - Lurasidone for schizophrenia: a review of the efficacy and safety profile for this newly approved second-generation antipsychotic JO - Int J Clin Pract VL - 65 UR - https://doi.org/10.1111/j.1742-1241.2010.02587.x DO - 10.1111/j.1742-1241.2010.02587.x ID - Citrome2011 ER - TY - JOUR AU - Citrome, L. PY - 2012 DA - 2012// TI - Lurasidone in schizophrenia: new information about dosage and place in therapy JO - Adv Ther VL - 29 UR - https://doi.org/10.1007/s12325-012-0052-6 DO - 10.1007/s12325-012-0052-6 ID - Citrome2012 ER - TY - JOUR AU - Hert, M. AU - Yu, W. AU - Detraux, J. AU - Sweers, K. AU - Winkel, R. AU - Correll, C. U. PY - 2012 DA - 2012// TI - Body weight and metabolic adverse effects of asenapine, iloperidone, lurasidone and paliperidone in the treatment of schizophrenia and bipolar disorder JO - CNS Drugs VL - 26 UR - https://doi.org/10.2165/11634500-000000000-00000 DO - 10.2165/11634500-000000000-00000 ID - Hert2012 ER - TY - JOUR AU - Newcomer, J. AU - Tocco, M. AU - Pikalov, A. AU - Zheng, H. AU - Cucchiaro, J. AU - Loebel, A. PY - 2016 DA - 2016// TI - Metabolic syndrome in patients with schizophrenia receiving long-term treatment with lurasidone, quetiapine XR, or risperidone JO - Eur Psychiatry VL - 33 ID - Newcomer2016 ER - TY - JOUR AU - Ng-Mak, D. S. AU - Poon, J. L. AU - Rajagopalan, K. AU - Kleinman, L. AU - Roberts, L. AU - Revicki, D. A. PY - 2015 DA - 2015// TI - Qualitative study of patients’ preferences for bipolar depression treatment JO - Value Health VL - 18 UR - https://doi.org/10.1016/j.jval.2015.03.718 DO - 10.1016/j.jval.2015.03.718 ID - Ng-Mak2015 ER - TY - JOUR AU - Weiden, P. J. AU - Kozma, C. AU - Grogg, A. AU - Locklear, J. PY - 2004 DA - 2004// TI - Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia JO - Psychiatr Serv VL - 55 UR - https://doi.org/10.1176/appi.ps.55.8.886 DO - 10.1176/appi.ps.55.8.886 ID - Weiden2004 ER - TY - JOUR AU - Weiden, P. J. AU - Mackell, J. A. AU - McDonnell, D. D. PY - 2004 DA - 2004// TI - Obesity as a risk factor for antipsychotic noncompliance JO - Schizophr Res VL - 66 UR - https://doi.org/10.1016/S0920-9964(02)00498-X DO - 10.1016/S0920-9964(02)00498-X ID - Weiden2004 ER - TY - JOUR AU - Lieberman, J. A. AU - Stroup, T. S. AU - McEvoy, J. P. AU - Swartz, M. S. AU - Rosenheck, R. A. AU - Perkins, D. O. PY - 2005 DA - 2005// TI - Effectiveness of antipsychotic drugs in patients with chronic schizophrenia JO - N Engl J Med VL - 353 UR - https://doi.org/10.1056/NEJMoa051688 DO - 10.1056/NEJMoa051688 ID - Lieberman2005 ER - TY - JOUR AU - Knapp, M. AU - King, D. AU - Pugner, K. AU - Lapuerta, P. PY - 2004 DA - 2004// TI - Non-adherence to antipsychotic medication regimens: associations with resource use and costs JO - Br J Psychiatry VL - 184 UR - https://doi.org/10.1192/bjp.184.6.509 DO - 10.1192/bjp.184.6.509 ID - Knapp2004 ER - TY - JOUR AU - Panish, J. AU - Karve, S. AU - Candrilli, S. D. AU - Dirani, R. PY - 2013 DA - 2013// TI - Association between adherence to and persistence with atypical antipsychotics and psychiatric relapse among US Medicaid-enrolled patients with schizophrenia JO - J Pharm Health Serv Res VL - 4 UR - https://doi.org/10.1111/jphs.12004 DO - 10.1111/jphs.12004 ID - Panish2013 ER - TY - JOUR AU - Stroup, T. S. AU - Byerly, M. J. AU - Nasrallah, H. A. AU - Ray, N. AU - Khan, A. Y. AU - Lamberti, J. S. PY - 2013 DA - 2013// TI - Effects of switching from olanzapine, quetiapine, and risperidone to aripiprazole on 10-year coronary heart disease risk and metabolic syndrome status: results from a randomized controlled trial JO - Schizophr Res VL - 146 UR - https://doi.org/10.1016/j.schres.2013.01.013 DO - 10.1016/j.schres.2013.01.013 ID - Stroup2013 ER - TY - JOUR AU - Stroup, T. S. AU - McEvoy, J. P. AU - Ring, K. D. AU - Hamer, R. H. AU - LaVange, L. M. AU - Swartz, M. S. PY - 2011 DA - 2011// TI - A randomized trial examining the effectiveness of switching from olanzapine, quetiapine, or risperidone to aripiprazole to reduce metabolic risk: comparison of antipsychotics for metabolic problems (CAMP) JO - Am J Psychiatry VL - 168 UR - https://doi.org/10.1176/appi.ajp.2011.10111609 DO - 10.1176/appi.ajp.2011.10111609 ID - Stroup2011 ER - TY - JOUR AU - Uçok, A. AU - Gaebel, W. PY - 2008 DA - 2008// TI - Side effects of atypical antipsychotics: a brief overview JO - World Psychiatry VL - 7 UR - https://doi.org/10.1002/j.2051-5545.2008.tb00154.x DO - 10.1002/j.2051-5545.2008.tb00154.x ID - Uçok2008 ER - TY - JOUR AU - Weiden, P. J. AU - Newcomer, J. W. AU - Loebel, A. D. AU - Yang, R. AU - Lebovitz, H. E. PY - 2008 DA - 2008// TI - Long-term changes in weight and plasma lipids during maintenance treatment with ziprasidone JO - Neuropsychopharmacology VL - 33 UR - https://doi.org/10.1038/sj.npp.1301482 DO - 10.1038/sj.npp.1301482 ID - Weiden2008 ER - TY - JOUR AU - Gaal, L. F. PY - 2006 DA - 2006// TI - Long-term health considerations in schizophrenia: metabolic effects and the role of abdominal adiposity JO - Eur Neuropsychopharmacol VL - 16 UR - https://doi.org/10.1016/j.euroneuro.2006.06.005 DO - 10.1016/j.euroneuro.2006.06.005 ID - Gaal2006 ER - TY - STD TI - Humedica life sciences: detailed clinical data. Humedica, Boston. 2013. http://www.optum.ca/content/dam/optum/resources/productSheets/Optum_Humedica_NorthStar_brochure.pdf. Accessed 06 Mar 2017. UR - http://www.optum.ca/content/dam/optum/resources/productSheets/Optum_Humedica_NorthStar_brochure.pdf ID - ref35 ER - TY - JOUR AU - Deyo, R. A. AU - Cherkin, D. C. AU - Ciol, M. A. PY - 1992 DA - 1992// TI - Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases JO - J Clin Epidemiol VL - 45 UR - https://doi.org/10.1016/0895-4356(92)90133-8 DO - 10.1016/0895-4356(92)90133-8 ID - Deyo1992 ER - TY - JOUR AU - Tarricone, I. AU - Ferrari Gozzi, B. AU - Serretti, A. AU - Grieco, D. AU - Berardi, D. PY - 2010 DA - 2010// TI - Weight gain in antipsychotic-naive patients: a review and meta-analysis JO - Psychol Med VL - 40 UR - https://doi.org/10.1017/S0033291709990407 DO - 10.1017/S0033291709990407 ID - Tarricone2010 ER - TY - JOUR AU - Stahl, S. M. AU - Cucchiaro, J. AU - Simonelli, D. AU - Hsu, J. AU - Pikalov, A. AU - Loebel, A. PY - 2013 DA - 2013// TI - Effectiveness of lurasidone for patients with schizophrenia following 6 weeks of acute treatment with lurasidone, olanzapine, or placebo: a 6-month, open-label, extension study JO - J Clin Psychiatry VL - 74 UR - https://doi.org/10.4088/JCP.12m08084 DO - 10.4088/JCP.12m08084 ID - Stahl2013 ER - TY - JOUR AU - Fagiolini, A. AU - Kupfer, D. J. AU - Houck, P. R. AU - Novick, D. M. AU - Frank, E. PY - 2003 DA - 2003// TI - Obesity as a correlate of outcome in patients with bipolar I disorder JO - Am J Psychiatry VL - 160 UR - https://doi.org/10.1176/appi.ajp.160.1.112 DO - 10.1176/appi.ajp.160.1.112 ID - Fagiolini2003 ER - TY - JOUR AU - McEvoy, J. P. AU - Citrome, L. AU - Hernandez, D. AU - Cucchiaro, J. AU - Hsu, J. AU - Pikalov, A. PY - 2013 DA - 2013// TI - Effectiveness of lurasidone in patients with schizophrenia or schizoaffective disorder switched from other antipsychotics: a randomized, 6-week, open-label study JO - J Clin Psychiatry VL - 74 UR - https://doi.org/10.4088/JCP.12m07992 DO - 10.4088/JCP.12m07992 ID - McEvoy2013 ER - TY - JOUR AU - Citrome, L. AU - Weiden, P. J. AU - McEvoy, J. P. AU - Correll, C. U. AU - Cucchiaro, J. AU - Hsu, J. PY - 2014 DA - 2014// TI - Effectiveness of lurasidone in schizophrenia or schizoaffective patients switched from other antipsychotics: a 6-month, open-label, extension study JO - CNS Spectr VL - 19 UR - https://doi.org/10.1017/S109285291300093X DO - 10.1017/S109285291300093X ID - Citrome2014 ER - TY - JOUR AU - Blackburn, G. PY - 1995 DA - 1995// TI - Effect of degree of weight loss on health benefits JO - Obes Res VL - 3 UR - https://doi.org/10.1002/j.1550-8528.1995.tb00466.x DO - 10.1002/j.1550-8528.1995.tb00466.x ID - Blackburn1995 ER - TY - JOUR AU - Cawley, J. AU - Meyerhoefer, C. AU - Biener, A. AU - Hammer, M. AU - Wintfeld, N. PY - 2015 DA - 2015// TI - Savings in medical expenditures associated with reductions in body mass index among US adults with obesity, by diabetes status JO - Pharmacoeconomics VL - 33 UR - https://doi.org/10.1007/s40273-014-0230-2 DO - 10.1007/s40273-014-0230-2 ID - Cawley2015 ER - TY - JOUR AU - Green, C. A. AU - Yarborough, B. J. H. AU - Leo, M. C. AU - Yarborough, M. T. AU - Stumbo, S. P. AU - Janoff, S. L. PY - 2015 DA - 2015// TI - The STRIDE weight loss and lifestyle intervention for individuals taking antipsychotic medications: a randomized trial JO - Am J Psychiatry VL - 172 UR - https://doi.org/10.1176/appi.ajp.2014.14020173 DO - 10.1176/appi.ajp.2014.14020173 ID - Green2015 ER - TY - JOUR AU - Newall, H. AU - Myles, N. AU - Ward, P. B. AU - Samaras, K. AU - Shiers, D. AU - Curtis, J. PY - 2012 DA - 2012// TI - Efficacy of metformin for prevention of weight gain in psychiatric populations: a review JO - Int Clin Psychopharmacol VL - 27 UR - https://doi.org/10.1097/YIC.0b013e32834d0a5b DO - 10.1097/YIC.0b013e32834d0a5b ID - Newall2012 ER - TY - JOUR AU - Lee, C. M. Y. AU - Huxley, R. R. AU - Wildman, R. P. AU - Woodward, M. PY - 2008 DA - 2008// TI - Indices of abdominal obesity are better discriminators of cardiovascular risk factors than BMI: a meta-analysis JO - J Clin Epidemiol VL - 61 UR - https://doi.org/10.1016/j.jclinepi.2007.08.012 DO - 10.1016/j.jclinepi.2007.08.012 ID - Lee2008 ER - TY - JOUR AU - Franklin, R. AU - Zorowitz, S. AU - Corse, A. K. AU - Widge, A. S. AU - Deckersbach, T. PY - 2015 DA - 2015// TI - Lurasidone for the treatment of bipolar depression: an evidence-based review JO - Neuropsychiatr Dis Treat VL - 11 ID - Franklin2015 ER - TY - JOUR AU - Bushe, C. J. AU - Slooff, C. J. AU - Haddad, P. M. AU - Karagianis, J. L. PY - 2012 DA - 2012// TI - Weight change from 3-year observational data: findings from the worldwide schizophrenia outpatient health outcomes database JO - J Clin Psychiatry VL - 73 UR - https://doi.org/10.4088/JCP.11m07246 DO - 10.4088/JCP.11m07246 ID - Bushe2012 ER - TY - JOUR AU - Millen, B. A. AU - Campbell, G. M. AU - Beasley, C. M. PY - 2011 DA - 2011// TI - Weight changes over time in adults treated with the oral or depot formulations of olanzapine: a pooled analysis of 86 clinical trials JO - J Psychopharmacol VL - 25 UR - https://doi.org/10.1177/0269881110370505 DO - 10.1177/0269881110370505 ID - Millen2011 ER -